Oryx Dental’s cloud-based imaging software has received FDA clearance to be marketed directly to practices.
Oryx Dental announced that it has secured 510(k) FDA clearance for its imaging product, Oryx Imaging.
The FDA clearance will allow the cloud-based company to directly market and sell their imaging platform to dental practices.
Oryx Cloud Imaging software includes the ability to acquire, view, annotate, and organize dental radiographs and color images – integrating with most dental imaging devices, such as intraoral X-ray sensors, intraoral cameras, and scanners.
This open integration allows clinicians a wider choice of imaging products. Doctors can mix and match acquisition devices from a variety of manufacturers or consolidate costs on its dental management software, pulling all needed components into one platform.
It provides offices with a choice to have a single price-point, with no add-ons.
“Oryx offers a cloud-based image management solution that resolves many of the challenges experienced when using closed proprietary imaging systems,” said Rania Saleh DDS, chief executive officer of Oryx Dental Software. “The platform improves patient safety and accelerates care with seamless access to images that assists in case diagnosis and treatment.”
Oryx Cloud Imaging can be used as a standalone product that integrates into existing systems but is also designed to work with the Oryx dental practice management software.
Photo 204545609 © Grandbrothers | Dreamstime.com
